Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma

American Journal of Surgery

Volumn 208, Issue 3, 2014, Pages 450-456

  Katsuta, Eriko ^a   Tanaka, Shinji ^a   Mogushi, Kaoru ^b   Matsumura, Satoshi ^a   Ban, Daisuke ^a   Ochiai, Takanori ^a   Irie, Takumi ^a   Kudo, Atsushi ^a   Nakamura, Noriaki ^a   Tanaka, Hiroshi ^b   Tanabe, Minoru ^a   Arii, Shigeki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Aged; Fibrosis; Gene expression; Hepatocellular carcinoma; Non B non C hepatocellular carcinoma; Pre existing comorbidity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANDROGEN; ASPARTATE AMINOTRANSFERASE; INDOCYANINE GREEN; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CANCER SURGERY; COMORBIDITY; DISEASE FREE SURVIVAL; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; UPREGULATION;

AGED; FIBROSIS; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA; NON-B NON-C HEPATOCELLULAR CARCINOMA; PRE-EXISTING COMORBIDITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TREATMENT OUTCOME;

EID: 84906253479     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2014.01.015     Document Type: Article

References (35)

1. D.M. Parkin, F. Bray, and J. Ferlay et al. Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2001 153 156
2. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
3. T. Umemura, T. Ichijo, and K. Yoshizawa et al. Epidemiology of hepatocellular carcinoma in Japan J Gastroenterol 44 Suppl 19 2009 102 107
4. C.H. Cha, M.W. Saif, and B.H. Yamane et al. Hepatocellular carcinoma: current management Curr Probl Surg 47 2010 10 67
5. S.I. Hanish, and S.J. Knechtle Liver transplantation for the treatment of hepatocellular carcinoma Oncology (Williston Park) 25 2011 752 757
6. J. Huang, B.K. Li, and G.H. Chen et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy J Gastrointest Surg 13 2009 1627 1635
7. K. Oishi, T. Itamoto, and T. Kobayashi et al. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more J Gastrointest Surg 13 2009 695 701
8. S. Yamada, M. Shimada, and H. Miyake et al. Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma Hepatol Res 42 2012 454 458
9. E. Tsujita, T. Utsunomiya, and M. Ohta et al. Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older Surgery 147 2010 696 703
10. K. Takenaka, M. Shimada, and H. Higashi et al. Liver resection for hepatocellular carcinoma in the elderly Arch Surg 129 1994 846 850
11. H. Fujii, Y. Itoh, and N. Ohnishi et al. Factors associated with the overall survival of elderly patients with hepatocellular carcinoma World J Gastroenterol 18 2012 1926 1932
12. T. Namieno, A. Kawata, and N. Sato et al. Age-related, different clinicopathologic features of hepatocellular carcinoma patients Ann Surg 221 1995 308 314
13. J. Quackenbush Microarray analysis and tumor classification N Engl J Med 354 2006 2463 2472
14. E.B. Schroeder, R. Hanratty, and B.L. Beaty et al. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems Circ Cardiovasc Qual Outcomes 5 2012 645 653
15. S. Tanaka, S. Arii, and M. Yasen et al. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy Br J Surg 95 2008 611 619
16. J.M. Llovet, and J. Bruix Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma Hepatology 32 2000 679 680
17. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators Hepatology 28 1998 751 755
18. M. Kudo, H. Chung, and Y. Osaki Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 2003 207 215
19. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
20. G.P. Copeland, D. Jones, and M. Walters POSSUM: a scoring system for surgical audit Br J Surg 78 1991 355 360
21. K. Kiyosawa, T. Umemura, and T. Ichijo et al. Hepatocellular carcinoma: recent trends in Japan Gastroenterology 127 2004 S17 S26
22. N. Taura, K. Hamasaki, and K. Nakao et al. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan Oncol Rep 16 2006 837 843
23. T. Li, L.X. Qin, and X. Gong et al. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection Cancer 119 2013 126 135
24. C.C. Wu, W.L. Ho, and J.T. Chen et al. Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma Br J Surg 86 1999 1391 1396
25. K. Oishi, T. Itamoto, and H. Amano et al. Clinicopathologic features of poorly differentiated hepatocellular carcinoma J Surg Oncol 95 2007 311 316
26. S. Jonas, W.O. Bechstein, and T. Steinmüller et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086
27. M.H. Wu, W.L. Ma, and C.L. Hsu et al. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription Sci Transl Med 2 2010 32ra35
28. N. Nagasue, L. Yu, and H. Yukaya et al. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection Br J Surg 82 1995 542
29. A.J. Philp, I.G. Campbell, and C. Leet et al. The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors Cancer Res 61 2001 7426 7429
30. J.A. Engelman Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nat Rev Cancer 9 2009 550 562
31. S. Ramaswamy, N. Nakamura, and I. Sansal et al. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR Cancer Cell 2 2002 81 91
32. S. Tanaka, and J.R. Wands A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype J Clin Invest 98 1996 2100 2108
33. Y. Zheng, L. Yin, and H. Chen et al. miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma FEBS Lett 586 2012 2396 2403
34. R.S. Finn, R.T. Poon, and T. Yau et al. Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma J Hepatol 6 2013 1271 1277
35. H. Nie, Q. Cao, and L. Zhu et al. Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma PLoS One 8 2013 e61678